These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39384352)

  • 1. Effect of the geometry and severity of left ventricular hypertrophy on cardiovascular mortality in dialysis patients.
    Huang YC; Wu CK
    Kidney Res Clin Pract; 2024 Sep; ():. PubMed ID: 39384352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Hypertrophy Geometry and Vascular Calcification Co-Modify the Risk of Cardiovascular Mortality in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study.
    Chao CT; Liao MT; Wu CK
    J Atheroscler Thromb; 2023 Sep; 30(9):1242-1254. PubMed ID: 36567124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Geometry and Inferior Vena Cava Diameter Co-Modify the Risk of Cardiovascular Outcomes in Chronic Hemodialysis Patients.
    Wu CK; Wang M; Kao ZK; Yar N; Chuang MT; Chang TH
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064569
    [No Abstract]   [Full Text] [Related]  

  • 4. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease.
    de Roij van Zuijdewijn CL; Hansildaar R; Bots ML; Blankestijn PJ; van den Dorpel MA; Grooteman MP; Kamp O; ter Wee PM; Nubé MJ
    Am J Nephrol; 2015; 42(2):126-33. PubMed ID: 26382055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Rozenbaum Z; Finkelstein A; Zhitomirsky S; Topilsky Y; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
    Am Heart J; 2020 Feb; 220():184-191. PubMed ID: 31862472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: the Pamela study.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2015 Oct; 33(10):2133-40. PubMed ID: 26196652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
    Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
    Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.
    Mitsnefes MM; Daniels SR; Schwartz SM; Meyer RA; Khoury P; Strife CF
    Pediatr Nephrol; 2000 Sep; 14(10-11):898-902. PubMed ID: 10975295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study.
    Li T; Li G; Guo X; Li Z; Sun Y
    BMC Cardiovasc Disord; 2021 May; 21(1):238. PubMed ID: 33980151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum magnesium is a predictor of left ventricular hypertrophy in patients on dialysis.
    Balafa O; Dounousi E; Giannikouris I; Petrakis I; Georgoulidou A; Karassavidou D; Kokalis A; Stauroulopoulos A; Theodoridis M; Oikonomidis I; Triantafyllis G; Tsotsorou O; Tzannis K; Bacharaki D
    Int Urol Nephrol; 2023 Apr; 55(4):1015-1023. PubMed ID: 36279086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China.
    Wang H; Sun Y; Li Z; Guo X; Chen S; Ye N; Tian Y; Zhang L
    BMC Cardiovasc Disord; 2018 Apr; 18(1):62. PubMed ID: 29631555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial strain and left ventricular geometry: a meta-analysis of echocardiographic studies in systemic hypertension.
    Tadic M; Sala C; Carugo S; Mancia G; Grassi G; Cuspidi C
    J Hypertens; 2021 Nov; 39(11):2297-2306. PubMed ID: 34128494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.
    Zhao X; Zhu L; Jin W; Yang B; Wang Y; Ni M; Zhao Y; Gan L; Zuo L
    BMC Cardiovasc Disord; 2022 Feb; 22(1):55. PubMed ID: 35172749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Concentric Left Ventricular Hypertrophy in Obstructive Sleep Apnea Syndrome. A Meta-analysis of Echocardiographic Studies.
    Cuspidi C; Tadic M; Sala C; Gherbesi E; Grassi G; Mancia G
    Am J Hypertens; 2020 Apr; 33(4):310-315. PubMed ID: 31863113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the atherogenic index of plasma and left ventricular hypertrophy in patients with obstructive sleep apnea: a retrospective cross-sectional study.
    Sun M; Liang C; Lin H; Chen Z; Wang M; Fang S; Tian T; Yang Y; Tang Q; Zhang E; Tang Q
    Lipids Health Dis; 2024 Jun; 23(1):185. PubMed ID: 38867215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.